• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

截尾肿瘤生长延迟数据的分析方法。

Methods for analysis of censored tumor growth delay data.

作者信息

Stuschke M, Budach V, Bamberg M, Budach W

机构信息

Department of Radiotherapy, University of Essen, Federal Republic of Germany.

出版信息

Radiat Res. 1990 May;122(2):172-80.

PMID:2336463
Abstract

Growth delay times of experimental tumors after subcurative therapy may be censored because of intercurrent death of the host animals, limitations of the follow-up period, or the number of cured tumors. Under the general assumptions of log-normally distributed data and independence of the censoring event and the therapy effect, it is shown using computer simulations that the estimate of the median growth delay according to the product limit method of Kaplan and Meier, which allows inclusion of censored data, is unbiased. Omission of censored growth delay times from incomplete accrued data often leads to biased estimates. The power of statistical tests for qualitative comparison of two therapy groups with incomplete sets of data from growth assays was also studied. In the absence of censoring, the power of the different tests is about the same. At higher censoring rates of 40%, however, tests applicable to censored data (log-rank test, Gehan-Wilcoxon test) have a markedly higher power than tests applied to the reduced set of complete observed growth delays (mu test, t test). Although complete observation of tumor regrowth should be strived for, growth delay experiments with very delicate animal tumor models can easily result in censored data. The methods presented permit quantitative and qualitative analysis of growth delay data up to a censoring rate of over 30%, if growth delays and censoring events are independent.

摘要

亚根治性治疗后实验性肿瘤的生长延迟时间可能因宿主动物的并发死亡、随访期的限制或治愈肿瘤的数量而被截尾。在数据呈对数正态分布以及截尾事件与治疗效果相互独立的一般假设下,通过计算机模拟表明,根据允许纳入截尾数据的Kaplan-Meier乘积限方法对中位生长延迟的估计是无偏的。从不完整的累积数据中省略截尾的生长延迟时间通常会导致有偏估计。还研究了对来自生长试验的两组不完整数据进行定性比较的统计检验功效。在没有截尾的情况下,不同检验的功效大致相同。然而,在截尾率较高(40%)时,适用于截尾数据的检验(对数秩检验、Gehan-Wilcoxon检验)比应用于减少的完整观察到的生长延迟数据集的检验(μ检验、t检验)具有明显更高的功效。尽管应努力实现对肿瘤再生长的完整观察,但对于非常精细的动物肿瘤模型进行生长延迟实验很容易产生截尾数据。如果生长延迟和截尾事件相互独立,所提出的方法允许对高达30%以上截尾率的生长延迟数据进行定量和定性分析。

相似文献

1
Methods for analysis of censored tumor growth delay data.截尾肿瘤生长延迟数据的分析方法。
Radiat Res. 1990 May;122(2):172-80.
2
"Just Another Statistic".“只是又一个统计数字”
Oncologist. 1998;3(3):III-IV.
3
A generalized log-rank-type test for comparing survivals with doubly interval-censored data.一种用于比较双区间删失数据生存情况的广义对数秩检验。
Biom J. 2009 Aug;51(4):689-96. doi: 10.1002/bimj.200800253.
4
Exact, distribution free confidence intervals for late effects in censored matched pairs.用于截尾匹配对中迟发效应的精确、无分布置信区间。
Biom J. 2009 Feb;51(1):31-44. doi: 10.1002/bimj.200710486.
5
Estimating Determinants of Multiple Treatment Episodes for Substance Abusers.评估药物滥用者多次治疗情况的决定因素。
J Ment Health Policy Econ. 2001 Jun 1;4(2):65-77.
6
Sample size determination for comparing several survival curves with unequal allocations.用于比较几个不等分配的生存曲线的样本量确定。
Stat Med. 2004 Jun 15;23(11):1793-815. doi: 10.1002/sim.1771.
7
Semi-parametric and non-parametric methods for clinical trials with incomplete data.用于处理不完全数据的临床试验的半参数和非参数方法。
Stat Med. 2005 Feb 15;24(3):341-58. doi: 10.1002/sim.1963.
8
A Bayesian chi-squared goodness-of-fit test for censored data models.一种用于删失数据模型的贝叶斯卡方拟合优度检验。
Biometrics. 2010 Jun;66(2):426-34. doi: 10.1111/j.1541-0420.2009.01294.x. Epub 2009 Jul 23.
9
Statistical methods for describing developmental milestones with censored data: effects of birth weight status and sex in neonatal pigtailed macaques.用于描述删失数据下发育里程碑的统计方法:出生体重状况和性别对新生食蟹猴的影响
Am J Primatol. 2007 Dec;69(12):1313-24. doi: 10.1002/ajp.20440.
10
The statistical analysis of cancer inhibition/promotion experiments.癌症抑制/促进实验的统计分析。
Anticancer Res. 1993 Sep-Oct;13(5A):1357-63.

引用本文的文献

1
Analysing Tumour Growth Delay Data from Animal Irradiation Experiments with Deviations from the Prescribed Dose.分析动物辐照实验中与规定剂量存在偏差的肿瘤生长延迟数据。
Cancers (Basel). 2019 Aug 31;11(9):1281. doi: 10.3390/cancers11091281.
2
Confidence intervals for the difference of median failure times applied to censored tumor growth delay data.应用于删失肿瘤生长延迟数据的中位失败时间差异的置信区间。
Stat Biopharm Res. 2011;3(3):488-496. doi: 10.1198/sbr.2011.10020. Epub 2012 Jan 24.
3
Modeling human choroidal melanoma xenograft growth in immunocompromised rodents to assess treatment efficacy.
建立免疫缺陷啮齿类动物人脉络膜黑色素瘤异种移植模型评估治疗效果。
Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2693-701. doi: 10.1167/iovs.11-9265.
4
Assessing cytotoxic treatment effects in preclinical tumor xenograft models.评估临床前肿瘤异种移植模型中的细胞毒性治疗效果。
J Biopharm Stat. 2009 Sep;19(5):755-62. doi: 10.1080/10543400903105158.
5
Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo.用激动型TRAIL受体抗体HGS-ETR1和HGS-ETR2联合治疗结直肠肿瘤与放射治疗:体外增强效果及体内剂量依赖性生长延迟
Oncogene. 2006 Aug 24;25(37):5145-54. doi: 10.1038/sj.onc.1209516. Epub 2006 Apr 24.
6
Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.异环磷酰胺、达卡巴嗪、多柔比星和顺铂在人肉瘤异种移植瘤中的疗效。
Br J Cancer. 1994 Jul;70(1):29-34. doi: 10.1038/bjc.1994.245.